Literature DB >> 17683947

HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implications.

Vera Rebmann1, Holger Nückel, Ulrich Dührsen, Hans Grosse-Wilde.   

Abstract

HLA-G appears to be involved in regulatory functions counteracting the cellular immune response of T and NK cells by several pathways. We here summarize the HLA-G expression patterns in leukaemia with emphasis on the clinical relevance of this expression for disease progression. Especially in patients with B-chronic lymphocytic leukaemia (B-CLL) the HLA-G expression on B-CLL cells was strongly associated with a reduced treatment-free survival. The corresponding immunological parameters point to a broad immunosuppression in these patients. Thus, HLA-G seems to contribute to the impaired immune response in B-CLL supporting disease progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17683947     DOI: 10.1016/j.semcancer.2007.06.011

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  9 in total

1.  Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer.

Authors:  Emilie Lesport; Jeremy Baudhuin; Sylvie Sousa; Joel LeMaoult; Alessia Zamborlini; Nathalie Rouas-Freiss; Edgardo D Carosella; Benoit Favier
Journal:  Cell Mol Life Sci       Date:  2011-02-20       Impact factor: 9.261

Review 2.  Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?

Authors:  Laurence Amiot; Soldano Ferrone; Hans Grosse-Wilde; Barbara Seliger
Journal:  Cell Mol Life Sci       Date:  2010-11-10       Impact factor: 9.261

Review 3.  Chronic lymphocytic leukemia and autoimmunity: a systematic review.

Authors:  Kate Hodgson; Gerardo Ferrer; Emili Montserrat; Carol Moreno
Journal:  Haematologica       Date:  2011-01-17       Impact factor: 9.941

4.  Effect of HLA-G5 Immune Checkpoint Molecule on the Expression of ILT-2, CD27, and CD38 in Splenic B cells.

Authors:  Hana Rohn; Cordula Lang; Sabine Schramm; Falko M Heinemann; Mirko Trilling; Anja Gäckler; Oliver Witzke; Peter A Horn; Vera Rebmann
Journal:  J Immunol Res       Date:  2022-05-12       Impact factor: 4.493

5.  Determination of HLA-G Expression and Evaluation of Its Role as a Prognostic Factor in Chronic Lymphocytic Leukemia.

Authors:  Gulsum Ozet; Mesude Falay; Simten Dagdas; Funda Ceran
Journal:  J Clin Lab Anal       Date:  2015-08-24       Impact factor: 2.352

6.  Serum soluble HLA-E in melanoma: a new potential immune-related marker in cancer.

Authors:  Mathilde Allard; Romain Oger; Virginie Vignard; Jean-Michel Percier; Giulia Fregni; Aurélie Périer; Anne Caignard; Béatrice Charreau; Karine Bernardeau; Amir Khammari; Brigitte Dréno; Nadine Gervois
Journal:  PLoS One       Date:  2011-06-21       Impact factor: 3.240

Review 7.  The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases.

Authors:  Fabrício C Dias; Erick C Castelli; Cristhianna V A Collares; Philippe Moreau; Eduardo A Donadi
Journal:  Front Immunol       Date:  2015-02-02       Impact factor: 7.561

8.  Trogocytic intercellular membrane exchanges among hematological tumors.

Authors:  Joel LeMaoult; Julien Caumartin; Marina Daouya; Magdalena Switala; Vera Rebmann; Bertrand Arnulf; Edgardo D Carosella
Journal:  J Hematol Oncol       Date:  2015-03-14       Impact factor: 17.388

9.  HLA-G expression on blasts and tolerogenic cells in patients affected by acute myeloid leukemia.

Authors:  Grazia Locafaro; Giada Amodio; Daniela Tomasoni; Cristina Tresoldi; Fabio Ciceri; Silvia Gregori
Journal:  J Immunol Res       Date:  2014-03-13       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.